• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Decernotinib

Decernotinib

Product ID D364086
Cas No. 944842-54-0
Purity ≥99%
Product Unit SizeCostQuantityStock
1 mg $88.60 In stock
5 mg $184.00 In stock
25 mg $524.70 In stock
100 mg $1,056.20 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Decernotinib is a potent and selective inhibitor of JAK3. It exhibits anti-inflammatory effects in rat models of rheumatoid arthritis, while avoiding hematopoiesis, a problem with current non-selective JAK inhibitors. Methotrexate treatment is also improved when used in combination with decernotinib.

Product Info

Cas No.

944842-54-0

Purity

≥99%

Formula

C18H19F3N6O

Formula Wt.

392.39

IUPAC Name

N2-[2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)-4-pyrimidinyl]-N-(2,2,2-trifluoroethyl)-D-isovalinamide

Synonym

VX-509, VRT-831509, Adelitinib

Solubility

DMSO

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

D364086 MSDS PDF

Info Sheet

D364086 Info Sheet PDF

References

Farmer L., Ledeboer M., et al. Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases. J Med Chem. 58(18):7195-216 (2015). PMID: 26230873.

Elwood F., Witter D., et al. Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor. 361(2):229-44 (2017). PMID:28193636.

Genovese M., van Vollenhoven R., et al. VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 68(1):46-55 (2016). PMID: 26473751.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P465822

    Pluripotin

    Dual kinase and GTPase inhibitor.

    ≥98%
  • B022691

    Baricitinib

    Selective and reversible JAK inhibitor.

    ≥99%
  • T7033

    Trifluoperazine Dihydrochloride

    Phenothiazine; D1/2 and α1-adrenergic antagoni...

    ≥98%
  • E9417

    Exendin-4

    Peptide, GLP-1 analog found in Heloderma; GLP-1...

    ≥95%
  • N7604

    Naltriben

    δ2OR antagonist.

    ≥95%
  • N3323

    Nifuratel

    Nitrofuran derivative.

    ≥99%
  • G1210

    GDC-0623

    MEK inhibitor.

    ≥98%
  • A0002

    A66

    p110α PI3K inhibitor.

    ≥98%
  • G1855

    Gentiopicroside

    Secoiridoid glycoside found in Gentiana and Cep...

    ≥95%
  • T0115

    Taxol Side Chain Acid

    Side chain commonly attached to taxanes.

    ≥98%
  • D0808

    DCC-2036

    Abl inhibitor.

    ≥98%
  • H1992

    Hexaconazole

    Triazole; demethylation inhibitor.

    ≥95%
  • D5607

    Dobutamine Hydrochloride

    β1-adrenergic agonist, β2- and α1-adrenergic...

    ≥98%
  • B7977

    Butylated Hydroxytoluene

    Antioxidative food and cosmetics additive.

    ≥99%
  • A1616

    AEE-788

    Inhibitor of EGFR, HER2, VEGFR2, and FLT3.

    ≥98%
  • S9754

    Syntide 2

    Synthetic peptide, CDPK, PKC, CaMKII substrate....

    ≥95%
  • R0250

    Ranatensin

    Peptide found in amphibians.

    ≥98%
  • D1694

    Dexamethasone Acetate Monohydrate

    Steroid; glucocorticoid agonist.

    ≥98%
  • E846184

    Everolimus EP Impurity B

    Everolimus impurity

    ≥96% (mix of E/Z)
  • I5210

    INCB018424

    JAK1/2 inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only